Overview

A Study of PBI-200 With Ritonavir or Cobicistat in Healthy Volunteers

Status:
Completed
Trial end date:
2022-11-12
Target enrollment:
Participant gender:
Summary
This is a drug-drug interaction study in volunteers to evaluate the effect of ritonavir or cobicistat on the pharmacokinetics (PK) of PBI-200.
Phase:
Phase 1
Details
Lead Sponsor:
Pyramid Biosciences
Treatments:
Cobicistat
Ritonavir